UF Innovate | Accelerate Welcomes John Mayfield to Its Advisory Board
UF Innovate | Accelerate is honored to welcome John D. Mayfield, Ph.D., vice president of corporate and business development at EQRx, to its advisory board.
Resilience Turns to Harvard for Biologics Manufacturing Tech, Inks 5-Year R&D Pact
Resilience, a company developing technologies that overcome the challenges of manufacturing complex biological medicines, is turning to Harvard University to find some of those new solutions.
UF Innovate | Accelerate Receives International Soft Landings Designation
UF Innovate | Accelerate is pleased to announce its two business incubators, Sid Martin Biotech and The Hub, have received an official “Soft Landings” designation from the International Business Innovation Association (InBIA) for supporting international companies moving to Florida.
Oragenics Awarded a $250,000 Grant From the National Institute of General Medical Sciences (NIGMS) for the Continued Research and Development of Lantibiotics
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., announced that it was awarded a small business innovation research grant in the amount of $250,000 (Computer-aided Design for Improved Lantibiotics R41GM136034) for the company’s continued research and development of lantibiotics, including its collaborative program with the Biomolecular Sciences Institute at Florida International University (FIU).
AGTC: The New Leader in Ocular Gene Therapy With Sue Washer
Sue Washer, president and CEO of Applied Genetic Technologies Corporation (AGTC), discusses ocular gene therapy with the Eye Care Insider podcast host Joshua Mali, MD.
Learning About Entrepreneurship and Innovation Has Taught Her To Be a Better Student and Intern
While an undergrad at the University of Florida, Savannah Gardner learned the skills she needed to be a successful social media professional, but she never had the opportunity to put her knowledge into practice until she started as an intern with UF Innovate. Today, she manages several social media accounts and excels in everything she does.
Oragenics Initiates COVID-19 Challenge Study Evaluating Multiple Formulations of Its SARS-CoV-2 Vaccine Candidate
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc. announced the initiation of a study to evaluate the immunogenicity and viral load reduction impact of its SARS-CoV-2 vaccine candidate in a hamster challenge study.
TearClear Files Investigational New Drug (IND) Application To Begin Its Clinical Trial for TC-002 Latanoprost Ophthalmic Solution, 0.005%
UF startup and UF Innovate | Sid Martin Biotech company TearClear, a late clinical-stage ophthalmic pharmaceutical company, has filed an Investigational New Drug (IND) application to conduct a registrational study for its lead glaucoma candidate, TC-002 latanoprost ophthalmic solution, 0.005%.
AGTC Is Excited To Announce Seasoned Healthcare Financial and Operations Executive Jonathan I. Lieber As Their New Chief Financial Officer
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare retinal diseases, announced Jonathan I. Lieber as their new Chief Financial Officer.
Can Handheld DNA Testing Technology Stand Up to Seafood Fraud?
When LeeAnn Applewhite started running DNA analysis on commercial seafood samples in 2015, 75 percent of them – species ranging from grouper and snapper to catfish and shrimp – were mislabeled. “We were testing thousands of samples, and some of it was unintentional mislabeling; it was a bycatch species with [species like] grouper or snapper but the whole load was not erroneously labeled,” said Applewhite, co-founder and president of UF Innovate | Sid Martin Biotech graduate Applied Food Technologies.